Patrick Round Email & Phone Number

London, Gb

Responsible for all preclinical, clinical and manufacturing of Xention development projects via the virtual development model using third party providers. Xention specialises in drugs that modulate ion channels. Therapeutic areas; atrial fibrillation, cough (via Provesica) and dyslipidaemia (via Dezima)

Providing clinical and general development support for biotechnology companies

Cambridge, Cambs, Gb

Responsible for all the clinical and regulatory development activities for Chronocort, a delayed sustained release formulation of hydrocortisone for patients with Congenital Adrenal Hyperplasia and Addison's disease, using a novel tablet coating technology. Phoqus operated a Virtual Development model using third party providers and external consultants.

Us

Line management of the CAT Development functions of about 100 staff plus contractors: Manufacturing Process Development, Quality, Regulatory, Clinical Development, and Project Management based in Cambridge UK, a Development team of 17 in Palo Alto CA. Operational accountability for 60 manufacturing process development staff in AZ Sweden

Line management responsibility for all the development activities in Preclinical, Clinical, Regulatory, Biometrics, Project management, Pharmacovigilance and Quality Assurance. (Approx. 100 staff including contractors on 3 sites) Plus the responsibilities of Chief Medical OfficerTherapeutic areas covered - Inflammatory diseases such as Crohn's Disease, Rheumatoid Arthritis, Multiple Sclerosis and Psoriasis, Oncology and development work on marketed products. Phase I - IV

Director of Clinical Development phase IIa - IV global clinical trialsLine Management of up to 25 staff in clinical development and medical communicationsTherapeutic areas covered - type 2 diabetes, obesity, urology, analgesia, cardiovascularProject leader for TroglitazoneResponsible for phase IIIa and phase IIIb studies for Dutasteride now marketed as Avodart

Bagsværd, Dk

Clinical Project Manager for a fast acting insulin analogue for diabetes (insulin aspart now marketed as NovoLog), from phase I to IIIa Responsible for; clinical development plan, resource planning, initiation of First Time in Man, phase I and II clinical trials, planning phase IIIa. Trials were in US, Europe and Japan

For the, UK Operating Company, providing input to regulatory, clinical research, marketing and sales forceHead of department for Medical Affairs providing a medical information serviceTherapeutic areas covered - Diabetes, HRT, Growth, Haematology and Epilepsy.